Infinity Pharmaceuticals (INFI) ends a mid-stage trial of its pancreatic cancer treatment after...

|About: Infinity Pharmaceuticals,... (INFI)|By:, SA News Editor

Infinity Pharmaceuticals (INFI) ends a mid-stage trial of its pancreatic cancer treatment after results showed the drug wouldn't meet its primary goal. Shares of INFI are in a freefall, down 44.9% premarket.